High-throughput profiling of influenza A virus hemagglutinin gene at single-nucleotide resolution

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Wu, Nicholas C ^a,b   Young, Arthur P ^a   Al Mawsawi, Laith Q ^a   Olson, C Anders ^a   Feng, Jun ^a   Qi, Hangfei ^a   Chen, Shu Hwa ^c   Lu, I Hsuan ^c   Lin, Chung Yen ^c   Chin, Robert G ^a   Luan, Harding H ^a   Nguyen, Nguyen ^a   Nelson, Stanley F ^a,b   Li, Xinmin ^a   Wu, Ting Ting ^a   Sun, Ren ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c INSTITUTE OF INFORMATION SCIENCE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ;

BINDING SITE; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN; INFLUENZA A VIRUS (H1N1); MUTATION; PHENOTYPE; PROTEIN CONFORMATION; PROTEIN DOMAIN; SINGLE NUCLEOTIDE POLYMORPHISM; STRUCTURE ACTIVITY RELATION;

BINDING SITES; CELL LINE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; MODELS, MOLECULAR; MUTATION; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN CONFORMATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84900431101     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep04942     Document Type: Article

References (50)

1. Mardis, E. R. Next-generation dna sequencing methods. Annu Rev Genomics Hum Genet 9, 387-402 (2008).
2. Schena, M., Shalon, D., Davis, R. W. & Brown, P. O. Quantitative monitoring of gene expression patterns with a complementary dna microarray. Science 270, 467-470 (1995).
3. Barski, A. et al. High-resolution profiling of histone methylations in the human genome. Cell 129, 823-837 (2007). (Pubitemid 46802390)
4. Chen, K. & Pachter, L. Bioinformatics for whole-genome shotgun sequencing of microbial communities. PLoS Comput Biol 1, 106-112 (2005).
5. Mavromatis, K. et al. The fast changing landscape of sequencing technologies and their impact on microbial genome assemblies and annotation. PLoS One 7, e48837 (2012).
6. Wang, Z., Gerstein, M. & Snyder, M. Rna-seq: a revolutionary tool for transcriptomics. Nat Rev Genet 10, 57-63 (2009).
7. Hann, M. M. & Oprea, T. I. Pursuing the leadlikeness concept in pharmaceutical research. Curr Opin Chem Biol 8, 255-263 (2004). (Pubitemid 38759400)
8. Sanchez, C. et al. Grasping at molecular interactions and genetic networks in drosophila melanogaster using flynets, an internet database. Nucleic Acids Res 27, 89-94 (1999). (Pubitemid 29209408)
9. Brooks, B. R. et al. Charmm: the biomolecular simulation program. J Comput Chem 30, 1545-1614 (2009).
10. Kellogg, E. H., Leaver-Fay, A. & Baker, D. Role of conformational sampling in computing mutation-induced changes in protein structure and stability. Proteins 79, 830-838 (2011).
11. Koga, N. et al. Principles for designing ideal protein structures. Nature 491, 222-227 (2012).
12. Whitehead, T. A. et al. Optimization of affinity, specificity and function of designed influenza inhibitors using deep sequencing. Nat Biotechnol 30, 543-548 (2012).
13. Christen, B. et al. The essential genome of a bacterium. Mol Syst Biol 7, 528 (2011).
14. van Opijnen, T. & Camilli, A. Genome-wide fitness and genetic interactions determined by tn-seq, a high-throughput massively parallel sequencing method for microorganisms. Curr Protoc Microbiol Chapter 1, Unit1E.3 (2010).
15. Arumugaswami, V. et al. High-resolution functional profiling of hepatitis c virus genome. PLoS Pathog 4, e1000182 (2008).
16. Heaton, N. S., Sachs, D., Chen, C.-J., Hai, R. & Palese, P. Genome-wide mutagenesis of influenza virus reveals unique plasticity of the hemagglutinin and ns1 proteins. Proc Natl Acad Sci U S A 110, 20248-20253 (2013).
17. Neumann, G. et al. Generation of influenza a viruses entirely from cloned cdnas. Proc Natl Acad Sci U S A 96, 9345-9350 (1999). (Pubitemid 29374757)
18. Kinde, I., Wu, J., Papadopoulos, N., Kinzler, K. W. & Vogelstein, B. Detection and quantification of rare mutations with massively parallel sequencing. Proc Natl Acad Sci U S A 108, 9530-9535 (2011).
19. Nakajima, S. et al. Identification of the defects in the hemagglutinin gene of two temperature-sensitive mutants of a/wsn/33 influenza virus. Virology 154, 279-285 (1986). (Pubitemid 16026105)
20. Leung, H. S. Y. et al. Entry of influenza a virus with a 2,6-linked sialic acid binding preference requires host fibronectin. J Virol 86, 10704-10713 (2012).
21. Bloom, J. D. & Glassman, M. J. Inferring stabilizing mutations from protein phylogenies: application to influenza hemagglutinin. PLoS Comput Biol 5, e1000349 (2009).
22. Sun, X., Tse, L. V., Ferguson, A. D. & Whittaker, G. R. Modifications to the hemagglutinin cleavage site control the virulence of a neurotropic h1n1 influenza virus. J Virol 84, 8683-8690 (2010).
23. Tokuriki, N., Stricher, F., Schymkowitz, J., Serrano, L. & Tawfik, D. S. The stability effects of protein mutations appear to be universally distributed. J Mol Biol 369, 1318-1332 (2007). (Pubitemid 46770766)
24. Guo, H. H., Choe, J. & Loeb, L. A. Protein tolerance to random amino acid change. Proc Natl Acad Sci U S A 101, 9205-9210 (2004). (Pubitemid 38812853)
25. White, C. L. et al. A sialic acid-derived phosphonate analog inhibits different strains of influenza virus neuraminidase with different efficiencies. JMol Biol 245, 623-634 (1995).
26. Bullough, P. A., Hughson, F. M., Skehel, J. J. & Wiley, D. C. Structure of influenza haemagglutinin at the ph of membrane fusion. Nature 371, 37-43 (1994). (Pubitemid 24277462)
27. Pace, C. N. & Scholtz, J. M. A helix propensity scale based on experimental studies of peptides and proteins. Biophys J 75, 422-427 (1998). (Pubitemid 28311831)
28. Ekiert, D. C. et al. Antibody recognition of a highly conserved influenza virus epitope. Science 324, 246-251 (2009).
29. Throsby, M. et al. Heterosubtypic neutralizing monoclonal antibodies crossprotective against h5n1 and h1n1 recovered from human igm+ memory b cells. PLoS One 3, e3942 (2008).
30. Chen, J.-R., Ma, C. & Wong, C.-H. Vaccine design of hemagglutinin glycoprotein against influenza. Trends Biotechnol 29, 426-434 (2011).
31. Sui, J. et al. Structural and functional bases for broad-spectrum neutralization of avian and human influenza a viruses. Nat Struct Mol Biol 16, 265-273 (2009).
32. Corti, D. et al. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza a hemagglutinins. Science 333, 850-856 (2011).
33. Robins, W. P., Faruque, S. M. & Mekalanos, J. J. Couplingmutagenesis and parallel deep sequencing to probe essential residues in a genome or gene. Proc Natl Acad Sci U S A 110, E848-E857 (2013).
34. Acevedo, A., Brodsky, L. & Andino, R. Mutational and fitness landscapes of an rna virus revealed through population sequencing. Nature 505, 686-690 (2014).
35. Chu, C. et al. Functional analysis of conserved motifs in influenza virus pb1 protein. PLoS One 7, e36113 (2012).
36. Li, Z. et al. Mutational analysis of conserved amino acids in the influenza a virus nucleoprotein. J Virol 83, 4153-4162 (2009).
37. Stewart, S. M. & Pekosz, A. Mutations in the membrane-proximal region of the influenza a virus m2 protein cytoplasmic tail have modest effects on virus replication. J Virol 85, 12179-12187 (2011).
38. Boltz, D. A., Aldridge, J. R., Webster, R. G. & Govorkova, E. A. Drugs in development for influenza. Drugs 70, 1349-1362 (2010).
39. Memoli, M. J., Morens, D. M. & Taubenberger, J. K. Pandemic and seasonal influenza: therapeutic challenges. Drug Discov Today 13, 590-595 (2008).
40. Pinto, L. H. & Lamb, R. A. Controlling influenza virus replication by inhibiting its proton channel. Mol Biosyst 3, 18-23 (2007). (Pubitemid 44924954)
41. Tan, P. T., Khan, A. M. & August, J. T. Highly conserved influenza a sequences as t cell epitopes-based vaccine targets to address the viral variability. Hum Vaccin 7, 402-409 (2011).
42. Ehrhardt, C. et al. Interplay between influenza a virus and the innate immune signaling. Microbes Infect 12, 81-87 (2010).
43. Rossman, J. S. & Lamb, R. A. Autophagy, apoptosis, and the influenza virus m2 protein. Cell Host Microbe 6, 299-300 (2009).
44. Richt, J. A. & Garca-Sastre, A. Attenuated influenza virus vaccines with modified ns1 proteins. Curr Top Microbiol Immunol 333, 177-195 (2009).
45. Wu, N. C. et al. Systematic identification of h274y compensatory mutations in influenza a virus neuraminidase by high-throughput screening. J Virol 87, 1193-1199 (2013).
46. Li, H. & Durbin, R. Fast and accurate short read alignment with burrows-wheeler transform. Bioinformatics 25, 1754-1760 (2009).
47. Lou, D. I. et al. High-throughput dna sequencing errors are reduced by orders of magnitude using circle sequencing. Proc Natl Acad Sci U S A 110, 19872-19877 (2013).
48. Heinig, M. & Frishman, D. Stride: a web server for secondary structure assignment from known atomic coordinates of proteins. Nucleic Acids Res 32, W500-W502 (2004). (Pubitemid 38997383)
49. Gamblin, S. J. et al. The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science 303, 1838-1842 (2004). (Pubitemid 38374870)
50. Marsh, G. A., Hatami, R. & Palese, P. Specific residues of the influenza a virus hemagglutinin viral rna are important for efficient packaging into budding virions. J Virol 81, 9727-9736 (2007). (Pubitemid 350067677)